| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $5.5M | +2.1% |
| SG&A Expense | $4.0M | +31.3% |
| Operating Income | -$9.6M | -12.6% |
| Interest Expense | $50K | +0.0% |
| Net Income | -$9.5M | -14.1% |
| EPS (Basic) | -$0.63 | +10.0% |
| EPS (Diluted) | -$0.63 | +10.0% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.6M | -67.5% |
| Current Assets | $1.7M | -66.4% |
| Total Assets | $8.8M | -31.2% |
| Current Liabilities | $1.3M | -3.8% |
| Total Liabilities | $1.3M | -4.3% |
| Stockholders' Equity | $7.5M | -34.4% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.5M | -34.3% |
| Capital Expenditures | $57K | -63.6% |
| Investing Cash Flow | -$57K | +63.6% |
| Financing Cash Flow | $5.3M | +69.8% |
| Free Cash Flow | -$8.5M | -31.9% |